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Abstract: Selenoproteins are an elite group of proteins containing a rare amino acid, selenocysteine (Sec), encoded by the codon, 
UGA. In eukaryotes, incorporation of Sec requires a Sec insertion sequence (SECIS) element, a stem–loop structure located in the 
3'-untranslated regions of selenoprotein mRNAs. Here we report identification of a noncanonical form of SECIS element in 
Toxoplasma gondii and Neospora canine, single-celled apicomplexan parasites of humans and domestic animals. This SECIS has 
a GGGA sequence in the SBP2-binding site in place of AUGA previously considered invariant. Using a combination of 
computational and molecular techniques, we show that Toxoplasma and Neospora possess both canonical and noncanonical 
SECIS elements. The GGGA-type SECIS element supported Sec insertion in mammalian HEK 293 and NIH 3T3 cells and did so 
more efficiently than the natural mammalian SECIS elements tested. In addition, mammalian type I and type II SECIS elements 
mutated into the GGGA forms were functional but manifested decreased Sec insertion efficiency. We carried out computational 
searches for both AUGA and GGGA forms of SECIS elements in Toxoplasma and detected five selenoprotein genes, including 
one coding for a previously undescribed selenoprotein, designated SelQ, and two containing the GGGA form of the SECIS 
element. In contrast, the GGGA-type SECIS elements were not detected in mammals and nematodes. As a practical outcome of 
the study, we developed pSelExpress1, a vector for convenient expression of selenoproteins in mammalian cells. It contains an 
SBP2 gene and the most efficient tested SECIS element: an AUGA mutant of the GGGA-type Toxoplasma SelT structure.  
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SI Materials and Methods 
Materials. Chemicals used in the study were purchased from Sigma, restriction enzymes from Amersham 
Pharmacia, DNA purification kits from Qiagen, mammalian cell culture reagents and the HEK 293 cell 
line from Invitrogen, and NIH 3T3 cells from ATCC. Sequences of primers used in the study are 
available upon request. 
Databases and programs. Toxoplasma gondii, C. elegans, human and mouse genome sequences and 
nonredundant protein sequences (ftp://ftp.ncbi.nih.gov/genbank) were obtained from NCBI. SECISearch 
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was used for identification of candidate SECIS elements (1). BLAST and FASTA programs were used for 
similarity searches (2). 
Identification of homologs of known selenoprotein genes. A full set of known eukaryotic selenoproteins 
was used as query sequences and included all human selenoproteins (1), all Plasmodium falciparum 
selenoproteins (3), Chlamydomonas MsrA (4), Gallus gallus SelU (5), protein disulfide isomerase from 
Emiliania huxleyi (6) and Danio rerio Fep15 (7). A stand-alone version of TBLASTN and FASTA 
package were used for detection of nucleotide sequences corresponding to known selenoprotein families. 
A search for canonical Toxoplasma SECIS elements. A stand-alone version of SECISearch with the 
default pattern was used. The search procedure included the following steps: 
1. Analysis of primary nucleotide sequence and secondary structures. We used PatScan to search the 
target database for the candidates satisfying the NUGA__AA__GA pattern. This pattern represents almost 
all eukaryotic SECIS elements (8). The additional requirements were as follows: (i) distance between the 
quartet (NUGA) and the unpaired AA in the apical loop 10-13 nucleotides, (ii) length of the apical loop 
without the unpaired AA sequence 6-23 nucleotides, (iii) no more than one insertion, one deletion, and 
two mismatches in the stem preceding the unpaired AA, and (iv) presence of an additional stem upstream 
of the quartet. For each SECIS candidate found in the previous step, secondary structure was predicted 
and examined for consistency with the eukaryotic SECIS consensus model. Additional filters then 
excluded SECIS elements with more than two consecutive unpaired nucleotides and Y-shaped SECIS 
elements. 
2. Estimation of the free energy. RNAfold from Vienna RNA package was used to calculate the free 
energies for whole structures and separately for their upper stem-loops. The threshold value was -12.6 
kcal/mol for the whole structure and -3.7 kcal/mol for the upper stem-loop. 
3. Protein identification. Analysis of location of SECIS elements and identification of ORFs were carried 
out. Candidate structures located on the complementary strand were filtered out. 
4. ORF analysis. This final step consisted of sequence analyses of predicted ORFs and identification of 
candidate Sec-encoding UGA codons. 
A search for Toxoplasma noncanonical SECIS elements. The search for noncanonical SECIS elements 
was carried out as described above for canonical SECIS elements, except that NTGA was replaced by 
NGGA in the primary sequence. Although no non-canonical SECIS elements other than the GGGA-type 
structures were discovered by homology searches involving known selenoproteins, the search settings 
were relaxed to allow any nucleotide preceding GGA (or UGA) for better sensitivity. 
Analysis of mammalian and nematode genomes, and EST sequences. Analysis of human and mouse 
genomes was carried out as described in ref. 1, with search patterns modified to meet the modified SECIS 
consensus model (e.g., GGGA-and AUGA-type SECIS elements). Likewise, similar modifications were 
made in the nematode search procedure (10). In addition to completely sequenced genomes, the NCBI 
EST database was searched for the presence of NGGA-type SECIS elements. 
Cloning strategies. GFP-fusion constructs developed and used in the study are shown in the scheme in 
Fig. 3A. Selenoprotein H (SelH) cDNA containing the in-frame TGA codon but lacking the entire 3'-UTR 
was amplified and cloned into pEFGP-C3 (Clontech), and all subsequent constructs containing 
Toxoplasma SECIS elements were developed using this GFP-SelHD3'UTR fusion construct (construct 2 
in Fig. 3A). Toxoplasma SelT and SelS SECIS elements (130-bp region, constructs 3 and 5, respectively) 
or the sequences beginning with the corresponding stop codons and containing SECIS elements (»300-bp 
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region, constructs 4 and 6) were amplified and cloned immediately downstream of the SelH stop codon. 
The rationale was as follows: the SelH SECIS is located very close to the stop codon (construct 1). 
Therefore, the constructs having the 130-bp sequences of Toxoplasma SECIS elements were regarded as 
corresponding to substitution of the mammalian SECIS element with the Toxoplasma structures, whereas 
the constructs containing the 300-bp sequences of Toxoplasma SelT 3'-UTR or 350-bp sequence of 
Toxoplasma SelS 3'UTRs were substitutions that introduced the corresponding 3'-UTRs. 
We further mutated the GG bases in the SECIS quartet in both Toxoplasma SelT and SelS to AT (i.e., 
Toxoplasma GG to AT mutants). Likewise, the AT bases in GFP-mSelHwt, GFP-mSelSwt, and GFP-
mSelMwt (Fig. 4A) fusions were mutated to the GG (i.e., mouse AT to GG mutants) using QuickChange 
mutagenesis kit (Stratagene). 
The vector for expression of selenoproteins in mammalian cells was developed on the basis of 
pBudCE4.1 (Invitrogen). First, the C-terminal domain of rat SBP2 was cloned into the first cloning site 
for expression under the EF 1apromoter. Subsequently, the Toxoplasma SelT AT>GG SECIS was cloned 
into the second multiple cloning site. Finally, mouse GPx1 sequence containing an in-frame TGA codon, 
but lacking a 3'-UTR, was amplified and cloned into the vector. As a control, we used the construct 
wherein mGPx1-Toxoplasma SelT SECIS AT>GG mutant was cloned into pBudCE4.1 that did not have 
the rat SBP2 sequence. 
Cell culture, transfection, and metabolic labeling. Mouse NIH 3T3 and human HEK 293 cells were 
cultured in DMEM supplemented with 10% FBS, 100 units/ml penicillin, and 100 units/ml streptomycin. 
Cells were seeded in six-well plates and transfected as follows: NIH 3T3 cells using Lipofectamin and 
Plus reagent (Invitrogen) according to the manufacturer's protocol, and HEK 293 using the calcium-
phosphate method (9) in OPTI-MEM (Invitrogen), or cotransfected in a ratio of 2:1 with the rat SBP2 
expression construct (20) that was the generous gift of Drs. Paul Copeland and Donna Driscoll, Cleveland 
Clinic Foundation. In 12-24 h after transfection, the medium was replaced with DMEM supplemented 
with Se (specific activity 1,000 Ci/mmol), and the cells were incubated for an additional 12-24 h. 
SDS/PAGE and Western blot analysis. After transfection, cells were washed with PBS, harvested, lysed 
in 200 ml of lysis buffer (Sigma), electrophoresed using NuPAGE system (Invitrogen), and transferred 
onto PVDF membranes. The membranes were exposed to a PhosphorImager screen and metabolically 
labeled proteins were visualized using a PhosphorImager system (GE Healthcare). The membranes were 
then probed with anti-GFP rabbit antiserum (Invitrogen) as primary and anti-rabbit HRP-conjugated 
antibodies as secondary antibodies. The Western blot signals were then detected with an ECL system (GE 
Healthcare). 
Enrichment of recombinant His-tagged GPx1 protein on metal-affinity resin. Forty-eight hours after 
transfection of mammalian cells with various His tag-GPx1 expression constructs, the cells were 
harvested, lysed in PBS containing protease inhibitors (complete protease mixture, Roche) by brief 
sonication and centrifuged for 5 min. Supernatants were collected, normalized with respect to protein 
concentration using Bradford method (Bio-Rad), and mixed with TALON affinity resin (Clontech). Total 
protein (0.75 mg; 1 mg/ml, 750 ml) per 40-50 ml of the resin was used. The samples were incubated 
under delicate rotation for 1 h at 4°C. After incubation, the resins were washed extensively, and the bound 
proteins were eluted by heating in an SDS/PAGE loading buffer and analyzed by gel electrophoresis and 
immunoblotting. After analysis of Se-labeled proteins as described above, the membranes were probed in 
Western blots with anti-GPx1 antibodies (GeneTex) according to the manufacturer's protocol. 
 
Supporting Figure 1
C.reinhardtii
D.melanogaster
D.discoideum
H.sapiens
M.musculus
G.gallus
T.gondii
C.reinhardtii
D.melanogaster
D.discoideum
H.sapiens
M.musculus
G.gallus
T.gondii
1 ---------------------------------MPYISRTGTVQ-ERRSPWRLSIVVEFF 
1 ---------------------------------MVYIDHNGRVW-EKR-PWDWRRIVELF 
1 -----------------------------MPPKPTYVSGGSVTQ-TGRSKWRLSYIPEFI 
1 ---------------------------------MVYISNGQVLDSRSQSPWRLSLITDFF 
1 ---------------------------------MVYISNGQVLDSRNQSPWRVSFLTDFF 
1 ---------------------------------MVYISNGQVLDNRSRAPWSLSAITDFF 
1 MENEPSAAAPNPWASPGPVNSSSRGRARVINGQIVYGDEAGRPGSQSDARSSRQAVRPGL 
27 MGVWGAISTFFMTMVSPQAHEAYL--KQQVKKKDPPRTTGGPRIAGLDNIGGGGGSH---
26 VGIWFAIKQLFLTFLAPFTGNN----NQANPRRGNGWGGGGGWGGGGGGGGGGGGGRPGS 
31 WGILNQITFFFSTLIGGTVEPRRRPNNQGGGRRLAGFDGNGNVTGGSGVGGSGPSKGPDN 
28 WGIAEFVVLFFKTLLQQDVKKRRSYGNSSDSRYDDGRGPPGNPPRRMGRINHLRG-P---
28 WGIAEFVVFFFKTLLQQDVKKRRGYGSSSDSRYDDGRGPPGNPPRRMGRISHLRG-P---
28 WSIADFVVMFFQSIIQPDLR-RRGYTSSSYLGQSDGRGPPGNPRRRMGRINHWGGGP---
61 FVRLCAFLFALVDFIRLFFQTIFSPNYPNQGRRNRQMGGVASLTPGGGRPDGGGGSG---
*
C.reinhardtii
D.melanogaster
D.discoideum
H.sapiens
M.musculus
G.gallus
T.gondii
82 ----LTPG-----------C---AGGGUG--
82 GSGGLRPNRRIGRIQPTMSCNMPAGGGUG--
91 GSNNRRGD-----MKNILACNS-ASGSUGPK 
84 ----SPPP--------------MA-GGUGR-
84 ----SPPP--------------MA-GGUGR-
84 ----SPPP--------------MAGGGUGR-
118 ----SRPRYQQX--------FVCGGGGUG— 
Fig. 1. Multiple sequence alignments of apicomplexan selenoprotein SelK. Sequences with the 
following accession numbers were used in the alignment: TgEST_95058496 (T. gondii), AAH13162.2 
(H. sapiens), Q9JLJ1 (M. musculus), NP_001020612.1 (G. gallus), AAN32902.1 (C. reinhardtii), 
XP_646897.1 (D. discoideum), and NP_572763.3 (D. melanogaster). Selenocysteine residues (U) are 
highlighted in red and indicated by asterisks. 
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Supporting Figure 2
H.sapiens
M.musculus
D.rerio
C.reinhardtii W1
C.reinhardtii W2
T.gondii
N.caninum
1 MA---LAVRVVYCGAUGYKSKYLQLKKKLEDEFP----GRLDICGEGTPQATGFFEVMVA 
1 MA---LAVRVVYCGAUGYKPKYLQLKEKLEHEFP----GCLDICGEGTPQVTGFFEVTVA 
1 MT---VKVHVVYCGGUGYRPKFIKLKTLLEDEFP----NELEITGEGTPSTTGWLEVEVN 
1 MAP--VQVHVLYCGGUGYGSRYRSLENAIRMKFPN---ADIKFSFEATPQATGFFEVEVN 
1 MAKTSIAAQVVMCGGUGYRGRYRSLVEAYRRRFP----LWVPTSPTTQRCSLEAFEISVN 
1 MEQT-VEITIQFCGGUGYRPYFDRAEALIRSWLSDAELRRVSIEGHEDPGTTGNFEIRIN 
1 MART-VEITIQFCGGUGYRPYFDRAEALIRSWFTDVYFRHVSIEGHEDPGTTGNFEIRID 
H.sapiens 54 GKLIHSKK-KGDGYVDTESKFLKLV-AAIKAALAQG-
M.musculus 54 GKLVHSKK-RGDGYVDTESKFRKLV-TAIKAALAQCQ
D.rerio 54 GKLVHSKK-NGDGFVDSDSKMQKIV-TAIEQAMGK--
C.reinhardtii W1 56 GELVHSKK-NGGGHVDNQEKVERIF-AKIGEALAK--
C.reinhardtii W2 57 GGLVHSKE-KGMQFPYAPESWSGCT------------
T.gondii 60 GKLVHSKKTKKQGFLHANKEQQEVVRQKLKEALGN--
N.caninum 60 GVLVHSKKTRRQGFLHANKEQQEVVRQKIREALDN—
Fig. 2. Multiple sequence alignments of apicomplexan selenoprotein SelW. The alignment is based on 
the following sequences: NP_003000.1 (H. sapiens), NP_033182.1 (M. musculus), AAO86696.1 (D. 
rerio), BU654801.1 and BP092691.1 (C. reinhardtii), TgEST_95057361 (T. gondii), and TC2958 (N. 
caninum). Selenocysteine residues (U) are highlighted in red and indicated by asterisks. 
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Supporting Figure 3
1 MEEALR HSRLPKADQIQALNLLIKIVN GSAN
1 MEEALQ QSRLPKADQIQALNLLIKIVT PAAT
EMA NVLSPP PEELERFRCINSGSTALQQR 
EVA NILSPP PEEVERFRCINSGSTALQQR 
T.gondii
N.caninum
61 LLRHGPVYENLLLALGFYRTTEPPVSRPLPQPNQEYFFLPEHADRAQLLADLELLRATVA 
61 LLRHGPVYENLLLALGFYRTADPPLSCPLTQANQEYFFLPDHADGGRLLADLELLRATVA 
T.gondii
N.caninum
121 SLETEGD---DRMPAAERLT TGAPRKVTTTSRAIRDSSGAAHARNQEELRQLREEQ 
121 SLEAEGGNAIESSPTAERLN QGAQ SMHARNQEELRRLREEQ 
SGGS
SAGS RKVTTTSRAIRDSSA
T.gondii
N.caninum
T.gondii
N.caninum
178 RARFEQRSETQATGGITGWLSA SAAQPAQPRHPEPADVPTPGGSRREGSGGN 
181 RL EPAGGIAGWFSS PSAQPAG---P-------------------RFEQRSES
SLAPSASV
SLAPTASL
*
238 AASRFFKSLFGG GAANRRDRDSRGPRMKTIKDLPPAPQRRGUG 
219 --S-----LFGS DGTSQRGGDSRGPRMKTIKDLPPAPRRRGU
RSGSRSEEGHER
RSGSRSEEGRER G 
T.gondii
N.caninum
Fig. 3. Multiple sequence alignments of apicomplexan selenoprotein SelS-like. The following 
sequences were used in the alignment: TgTwinScan_4798 (T. gondii), and TC3699 and TC3703 (N. 
caninum). Selenocysteine residues (U) are highlighted in red and indicated by asterisks. 
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Supporting Figure 4 
H.sapiens 1 -------------------------------------------------------MRLLL
G.gallus 1 ------------------------------------------------------------
C.elegans 1 --------------------------------------MRIHDELQKQDMSRFGVFIIGV
O.sativa 1 -------------------------------------------------MDRVQLVLLGL
A.thaliana 1 -------------------------------------------------MDKTQLILLGL
T.gondii 1 MVPSEGAAPSGGG--GAS---------TVSPGTSSPLPSS-----SSTWVVAAVVLLLSL
N.caninum 1 MAVPQGVVPPGGGDSGGSRGHSVTADATTPPATQTSSPAAPPTSLSSTWIVALVVLLLSL
C.reinhardtii 1 -----------------------------------------------MQGLHKGAILLGI
H.sapiens 6 LLLVAASAMVRSEASANLGGVPSKRLKMQYATG---------------------------
G.gallus 1 ---------------------------MAYATG---------------------------
C.elegans 23 LFFMSVCDVLRTEEHSHDENHVHEKDDFEAEFGDETDSQSFSQGTEEDHIEVREQSSFVK
O.sativa 12 PILLFCSDLVTLFGPEQLPTPQPDLPPHPSPDAASDAVQP------DDIAADAAASAQIA
A.thaliana 12 PIFLLCSDLFNLFTP---PPPK---SQHQSPPSISETL---------DFPAQKST-----
T.gondii 45 PLGTVLDGLFLSGNHAPMQSAPSTLVDRFFTPHN--------------------------
N.caninum 61 PLGTVIDGLFSPSGNRGSSSASPVLFEQLFTPHN--------------------------
C.reinhardtii 14 VALFIGADCFGVMGGSKAPSQARVQSAMDPDGGLS-------------------------
*
H.sapiens
G.gallus
C.elegans
O.sativa
A.thaliana
T.gondii
N.caninum
C.reinhardtii
H.sapiens
G.gallus
C.elegans
O.sativa
A.thaliana
T.gondii
N.caninum
C.reinhardtii
H.sapiens
G.gallus
C.elegans
O.sativa
A.thaliana
T.gondii
N.caninum
C.reinhardtii
39 ----------PLLKFQICVSUG---YRRVFEEYMRVISQRYPDIRIEGENYLPQPIYRHI 
7 ----------PLLKFQICVSUG---YRRVFEEYMRVISQRYPDIRIEGENYLPQPIYRHI 
83 PTAVHHAKDLPTLRIFYCVSCG---YKQAFDQFTTFAKEKYPNMPIEGANFAPVLWKAYV 
66 EPQVDGPASGTTVELKFCASCS---YRGNAVTVKKMLETSFPGIHVVLENYPPPFPKRAL 
52 -----GVGYGNTVEINFCISCS---YKGTAVSMKKMLESVFPGLDVVLANYPAPAPKRIL 
79 --PLPTGISPHQVTVQLCTSUSSAGALRQLAEFLSFQLSHLPGFRFVAVEYKPSLFHQAL 
95 --PLPADVGPHQVTVQLCTSUSTAGALRQLADFLSFQLNHLPGFRLVAVDYRPSLFHQAL 
49 --------LGGKLHVSFCNSUGMRGA---FVQVMELARRRYPGLEVVGTPYPLPAWKVPV 
86 ASFLSVFKLVLIGLIIVGKDPFAFF------------GMQAPSIWQWGQ-ENKVYACMMV 
54 ASFLSVFKLVLIGLIIVGKDPFAFF------------GMQAPSIWQWGQ-ENKVYACMMV 
140 AQALSFVKMAVLVLVLGGINPFERF------------GLGYPQILQHAH-GNKMSSCMLV 
123 SKAVPFLQVGAMATLMAGDQIFPRF------------GMVPPP-WYYSLRANRFGTMATI 
104 AKVVPVAQVGVIGLIMGGEQIFPMI------------GIAQPPAWYHSLRANRFGSMAST 
137 GRLLDALSWAALALVVFVRPICSTLGLTQQRGEERGAQTEQLPPWAEALENNRVAAIVTA 
153 GRLLDVLSWAALALVVFVRPICAALGLTQ-RGGEGSAQAEQLPPWAEALENNRVTAIISA 
98 VKALQVVQFGLLGMCLAGDKVFAAL------------GVPVPAWYTQNVASNRFGAAMGV 
133 FFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNEMKLN----VHMD 
101 FFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNEMKLN----VHME 
187 FMLGNLVEQSLISTGAFEVYLGNEQIWSKIESGRVPSPQEFMQLIDAQLAVLGKAPVNTE 
170 WLFGNFAQSFLQSSGAFEVYCNGQLVFSKLSEQRFPSEFELRELIGNRLPDS----QFGK 
152 WLLGNFLQSFLQSSGAFEVSCNGELVFSKLKEGRFPGEIELRDLSSGTMTKP----FVTG 
197 FFGVQVVRSVLIPNNAFEIFIGENLLWSTLDSGRMPNGRDLMQRLETIGVSVR------E 
212 FFGAQVVRSVLIPSFSFEIYFGPNLLWSTVHNGRMPNGRDLLRELEALGVRVR------D 
146 WFVGNMVVTNMQNTGAFEVFFNGDLIFSKLAEGRMPSVPELISPMQAFFEGPAGLHVGGA 
H.sapiens 189 SIPHHRS-----------------------
G.gallus 157 SMPHHRS-----------------------
C.elegans 247 SFGEFQQTV---------------------
O.sativa 226 NLEKVWS-----------------------
A.thaliana 208 SY----------------------------
T.gondii 251 PM----------------------------
N.caninum 266 PM----------------------------
C.reinhardtii 206 GASRPGLTGAGMGHGPELSGVGAAAVGLTG 
Fig. 4. Multiple sequence alignments of apicomplexan selenoprotein SelT. Accession numbers of the 
sequences are as follows: AAH26350.2 (H. sapiens), NP_001006557.2 (G. gallus), CAB01684.1 (C. 
elegans), NP_915340.1 (O. sativa), BAD43801.1 (A. thaliana), BQ818029.1 (C. reinhardtii), 
TgESTzyi41b04.y1 and TgESTzyd07e11.y1 (T. gondii), and TC2223 and TC1872 (N. caninum). 
Selenocysteine residues (U) are highlighted in red and indicated by asterisks. 
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Supporting Figure 5
Fig. 5. Evaluation of band intensities in the western blots in Figure 4. 
Quantification of bands for HEK 293 (blue) and NIH 3T3 (green) cells is shown in 
absolute values for each lane. Logarithmic scale is used for representation of intensity 
ratio of full-length and truncated forms of proteins (lower panels). Numbering is the same 
as in Figure 2. Scion Image 4.0 software (Scion Corporation) was used for image 
processing and analysis. 
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Supporting Figure 6
C. elegans genome 
(100.3 Mbp) 
C. briggsae genome 
(104 Mbp) 
Primary structure 
analysis 
Primary structure 
analysis 
15443 19368 
1934 2896 
Additional 
filters 
Additional 
filters 
Thermodynamic 
evaluation 
Thermodynamic 
evaluation 
523 
BLASTN (e<10-5) 
Analysis of 
flanking regions 
820 
180 
No selenoproteins 
Fig. 6. Analysis of nematode genomes with a modified version of SECISearch. Each step in 
the search procedure is shown as a separate box, with the numbers of SECIS candidates indicated 
in red for C. elegans and in blue for C. briggsae. 
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Supporting Figure 7
H.sapiens genome 
(3,048 Mbp) 
M.musculus genome 
(2,646 Mbp) 
Primary structure 
analysis 
Primary structure 
analysis 
1,015,198 919,442 
112,465 102,070 
Additional 
filters 
Additional 
filters 
Thermodynamic 
evaluation 
Thermodynamic 
evaluation 
29,864 
BLASTN (e<10-10) 
Analysis of 
flanking regions 
29,255 
202 
No selenoproteins 
Fig. 7. Analysis of human and mouse genomes. Numbers shown in red correspond to SECIS 
candidates in H. sapiens, and those in blue to SECIS candidates in M. musculus. 
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Supporting Figure 8
EST database 
(~18,000,000,000 nucl.) 
Thermodynamic 
evaluation 
Primary/secondary 
structure analysis 
683,698 SECIS 
Additional 
5,978,113 SECIS 
filters
Clustering of SECIS elements 
Manual analysis of 
flanking regions 
146,040 SECIS 
593 clusters of SECIS 
4 selenoproteins 
Fig. 8. Analysis of NCBI EST database. SECIS candidates identified in each step are indicated. 
Only SelT and SelS from T. gondii and N. caninum were identified in this search. 
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Supporting Figure 9
Fig. 9. Evaluation of band intensities in the western blots in Figure 4. 
Quantification of bands for HEK 293 (blue) and NIH 3T3 (green) cells is shown in 
absolute values for each lane. Logarithmic scale is used for representation of intensity 
ratio of full-length and truncated forms of proteins (lower panels). Numbering is the same 
as in Figure 4. Scion Image 4.0 software (Scion Corporation) was used for image 
processing and analysis. 
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